WKN: | A11QVV |
ISIN: | DE000A11QVV0 |
Land: | Deutschland |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Heidelberg Pharma-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 24. Juli 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2020 | 2,14 | 6,98 | 226,17% |
2 | 2009 | 7,34 | 13,52 | 84,25% |
3 | 2025 | 2,32 | 3,89 | 67,67% |
4 | 2017 | 2,20 | 3,21 | 46,29% |
5 | 2016 | 1,55 | 2,20 | 41,65% |
6 | 2013 | 3,84 | 5,11 | 33,21% |
7 | 2010 | 13,52 | 16,02 | 18,42% |
8 | 2022 | 4,71 | 4,85 | 2,97% |
9 | 2015 | 1,70 | 1,55 | -8,66% |
10 | 2019 | 2,42 | 2,14 | -11,57% |
11 | 2011 | 16,02 | 12,46 | -22,19% |
12 | 2018 | 3,21 | 2,42 | -24,70% |
13 | 2023 | 4,85 | 3,65 | -24,74% |
14 | 2021 | 6,98 | 4,71 | -32,52% |
15 | 2024 | 3,65 | 2,32 | -36,44% |
16 | 2007 | 40,79 | 20,47 | -49,82% |
17 | 2008 | 20,47 | 7,34 | -64,14% |
18 | 2014 | 5,11 | 1,70 | -66,77% |
19 | 2012 | 12,46 | 3,84 | -69,22% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2012 | 12,46 | 3,84 | -69,22% |
2 | 2014 | 5,11 | 1,70 | -66,77% |
3 | 2008 | 20,47 | 7,34 | -64,14% |
4 | 2007 | 40,79 | 20,47 | -49,82% |
5 | 2024 | 3,65 | 2,32 | -36,44% |
6 | 2021 | 6,98 | 4,71 | -32,52% |
7 | 2023 | 4,85 | 3,65 | -24,74% |
8 | 2018 | 3,21 | 2,42 | -24,70% |
9 | 2011 | 16,02 | 12,46 | -22,19% |
10 | 2019 | 2,42 | 2,14 | -11,57% |
11 | 2015 | 1,70 | 1,55 | -8,66% |
12 | 2022 | 4,71 | 4,85 | 2,97% |
13 | 2010 | 13,52 | 16,02 | 18,42% |
14 | 2013 | 3,84 | 5,11 | 33,21% |
15 | 2016 | 1,55 | 2,20 | 41,65% |
16 | 2017 | 2,20 | 3,21 | 46,29% |
17 | 2025 | 2,32 | 3,89 | 67,67% |
18 | 2009 | 7,34 | 13,52 | 84,25% |
19 | 2020 | 2,14 | 6,98 | 226,17% |